Literature DB >> 25186975

Long-range stabilization of anthrax protective antigen upon binding to CMG2.

Vennela Mullangi1, Sireesha Mamillapalli, David J Anderson, James G Bann, Masaru Miyagi.   

Abstract

Protective antigen (PA) mediates entry of edema factor (EF) and lethal factor (LF) into the cytoplasmic space of the cells through the formation of a membrane-spanning pore. To do this, PA must initially bind to a host cellular receptor. Recent mass spectrometry analysis of PA using histidine hydrogen-deuterium exchange (His-HDX) has shown that binding of the von Willebrand factor A (vWA) domain of the receptor capillary morphogenesis protein-2 (CMG2) lowers the exchange rates of the imidazole C2 hydrogen of several histidines, suggesting that receptor binding decreases the structural flexibility of PA. Here, using His-HDX and fluorescence as a function of denaturant, and protease susceptibility, we show that binding of the vWA domain of CMG2 largely increases the stability of PA and the effect reaches up to 70 Å from the receptor binding interface. We also show that the pKa values and HDX rates of histidines located in separate domains change upon receptor binding. These results indicate that when one end of the protein is anchored, the structure of PA is tightened, noncovalent interactions are strengthened, and the global stability of the protein increases. These findings suggest that CMG2 may be used to stabilize PA in future anthrax vaccines.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25186975      PMCID: PMC4179592          DOI: 10.1021/bi500718g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


The anthrax protective antigen (PA) is the receptor binding component of the anthrax toxin, a complex of proteins that mediates the pathogenicity of anthrax disease. After binding to the receptor, PA undergoes proteolytic processing by a furin-like protease, which cleaves off the N-terminal 167 amino acid residues of PA within domain 1 (residues 1–258), termed PA20.[1] PA20 subsequently dissociates and leaves behind domain 1′ (residues 168–258) and the three remaining domains, constituting a 63 kDa fragment (PA63). This fragment then oligomerizes into either a heptameric[2] or octameric[3] structure termed the prepore. Binding of PA to the receptor hijacks the host cell receptor to allow targeting of the other two components of the anthrax toxin, lethal factor (LF) and edema factor (EF), to the host cell surface. Once the prepore has formed, the toxin is internalized by receptor-mediated endocytosis. The structural details of PA binding to the host cell receptor capillary morphogenesis protein-2 (CMG2) are known, bound to either the monomeric 83 kDa PA[4] or the heptameric prepore.[2] Both structural and biochemical studies of the PACMG2 complex indicate that the binding interface is comprised of domain 4 and a small loop from domain 2 (2β3–2β4 loop), which inserts into a groove on the surface of CMG2 (Figure 1).[2,4−6] The binding affinity between PA and CMG2 is very high (Kd ∼ 200 pM)[7] and increases at acidic pH.[8] At the same time, receptor binding has been shown to improve the stability of the heptameric form of PA to pH and to facilitate the internalization of the toxin-bound prepore.[9,10] Our recent NMR study of PA labeled with 5-fluorotryptophan also suggested that receptor binding significantly stabilizes PA to both pH and temperature.[11]
Figure 1

Structure of the PA–CMG2 complex (PDB entry 1T6B). Eight histidine residues are shown (green sticks). Domain 1, Ser15–Ala258 (magenta); domain 2, Tyr259–Thr487 (blue); domain 3, Thr488–Arg595 (pink); domain 4, Phe596–Ile734 (yellow); vWA domain of CMG2 (orange). All the histidine residues in PA except His304 and His310 are shown. His304 and His310 are not observed in the structure. The 2β3–2β4 loop of domain 2 is also indicated.

Structure of the PACMG2 complex (PDB entry 1T6B). Eight histidine residues are shown (green sticks). Domain 1, Ser15Ala258 (magenta); domain 2, Tyr259Thr487 (blue); domain 3, Thr488Arg595 (pink); domain 4, Phe596Ile734 (yellow); vWA domain of CMG2 (orange). All the histidine residues in PA except His304 and His310 are shown. His304 and His310 are not observed in the structure. The 2β3–2β4 loop of domain 2 is also indicated. To further investigate the changes in stability of PA upon CMG2 binding, we used a histidine hydrogendeuterium exchange (His-HDX) method,[12] which monitors the slow rate of HDX of the C2 hydrogen of the imidazole group of histidine, and followed the rate of HDX as a function of increasing concentrations of guanidinium hydrochloride (Gdn-HCl).[13] Thus, using this method, we can measure the equilibrium unfolding of specific histidine residues within the protein. There are 10 histidine residues in PA that are scattered throughout the molecule, one in the PA20 domain, two in domain 1′, five in domain 2, and two in domain 4. Herein, we show that receptor binding leads to a significant shift in the concentration of Gdn-HCl required for full HDX (unfolding) of histidines located in separate domains, suggesting that receptor binding has a global effect on the thermodynamic stability of the protein. These studies are corroborated using fluorescence, in which we were able to probe selectively fluorescence changes in PA using a 4-fluorotryptophan-labeled von Willebrand factor A (vWA) domain of CMG2, which is nonfluorescent. His-HDX-MS also allowed us to determine the pKa and more accurate solvent accessibilities of the histidines in the presence and absence of the receptor and reveal differences in the microenvironment around the histidine residues as a consequence of receptor binding. Our results indicate that receptor binding has a profound long-range impact on the stability and structure of PA, suggesting that, with a limit on hingelike motions between domain 2 and domain 4, the protein can be made to be significantly more stable. Because PA is the major antigenic component of the current anthrax vaccine, our studies would indicate that addition of CMG2 to a vaccine formulation could improve the stability and overall efficacy of the vaccine.

Materials and Methods

Materials

Deuterium oxide (D2O, 99%) was purchased from Cambridge Isotope laboratories (Andover, MA), and guanidine hydrochloride (Gdn-HCl), deuterium chloride (DCl), and sodium deuteroxide (NaOD) were from Sigma-Aldrich (St. Louis, MO). Lys-C was purchased from Wako Chemicals USA (Richmond, VA); chymotrypsin and thermolysin were from Sigma-Aldrich, and Glu-C was from Worthington Biochemical (Lakewood, NJ). All other chemicals and materials used were either reagent grade or of the highest quality commercially available.

Protein Expression and Purification

PA and the vWA domain of CMG2, encoding residues 38–218, were expressed and purified as described previously.[14−16] Labeling of CMG2 with 4-fluorotryptophan was conducted using the tryptophan auxotroph DL41 (provided as a gift from the Yale E. coli Genetic Stock Center). 4-Fluorotryptophan was purchased from Gold Biotechnology (St. Louis, MO).

Unfolding Experiments Followed by His-HDX

PA alone (0.5 nmol) and the PACMG2 complex (0.5 nmol of PA and 2.5 nmol of CMG2) were incubated in 100 μL of 100 mM HEPES (pH* 7.5) made with D2O containing 1 mM MgCl2 and various concentrations of Gdn-HCl for 48 h at 37 °C. The pH* of the buffer was adjusted with diluted NaOD with a Solution Analyzer model 4603 instrument (Amber Science, Eugene, OR) equipped with a glass AgCl electrode (model 476086, Nova Analytics, Woburn, MA). The reported pH* values are direct pH meter readings of the D2O buffer solutions calibrated with standard buffer solutions made with H2O and are uncorrected for the isotope effect at the glass electrode. The reaction was stopped by adding 10 μL of formic acid, and the protein was freed from the salts using an Ultra Micro Spin C4 column (Nest Group, Southboro, MA) following the manufacturer’s instructions and dried in a Speed Vac. The protein was then redissolved in 60 μL of 100 mM ammonium bicarbonate and digested by 2 μg of Lys-C for 30 min at 25 °C. The reaction was stopped by adding 10 μL of formic acid, and the digest was divided into three parts and then dried in a Speed Vac. Two parts were further digested, one part by 1 μg of Glu-C for 30 min and other part by 1 μg of chymotrypsin for 30 min. The resulting three digests were dried in a Speed Vac and redissolved in 30 μL of 0.1% trifluoroacetic acid (TFA). The three digests at particular Gdn-HCl concentrations were mixed and analyzed by liquid chromatography and tandem mass spectrometry (LC–MS/MS) using a Qstar quadrupole/time-of-flight mass spectrometer (Applied Biosystems-MDS Sciex, Foster City, CA) equipped with a TurboIonSpray ion source. The protein digests were injected into a reverse-phase C18 column (500 mm × 0.1 mm, Waters); the peptides were chromatographed using a linear gradient of acetonitrile from 2 to 50% in aqueous 0.1% formic acid over a period of 40 min at a rate of 30 μL/min, and the elute was directly introduced into the mass spectrometer. The total ion current was obtained in the mass range of m/z 400–2000 in the positive ion mode with an acquisition time of 1 s for each scan. The pseudo-first-order rate constant (k) of the HDX reaction was determined by monitoring changes in the ratios of the M + 1/M isotopic peak of a given peptide before (time zero) and after (time t) the HDX reaction, and fitting the data to a first-order rate equation,[17] and the values were corrected upward to offset the decreased solvent concentration caused by the volume effect of Gdn-HCl. The relationship between solvent concentration and Gdn-HCl concentration was experimentally determined, from which the correction factor to correct the rate constant of the HDX reaction in Gdn-HCl solutions was obtained (text and Figure S1 of the Supporting Information). The corrected HDX rate was plotted against the concentration of Gdn-HCl. From the plot, the midpoint (Cm) of the Gdn-HCl-induced unfolding transition was estimated by fitting the denaturation curve to a two-state model. The free energy change (ΔG°) in PA denaturation was estimated from the plot by calculating the equilibrium constant (Keq) of denature/native protein at each Gdn-HCl concentration as follows.where k is the first-order His-HDX rate constant at a specific Gdn-HCl concentration, kN is the k for the native protein (k at 0 M Gdn-HCl), and kD is the k for the fully denatured protein (can be obtained from the plateau of the sigmoidal curve). The Keq value was used to determine the free energy change of denaturation at each Gdn-HCl concentration with the equationwhere R is the gas constant and T is the absolute temperature in kelvin. By plotting the ΔG° values against the concentrations of Gdn-HCl and extrapolating the fitted line to 0 M Gdn-HCl, we obtained ΔG°water in the absence of Gdn-HCl.

Unfolding Experiments Followed by Fluorescence Spectroscopy

PA alone and PA (1 μmol) complexed with 4-fluorotryptophan-labeled CMG2 (4-FTrpCMG2, 2 μmol) in 100 mM HEPES (pH 7.5) containing 1 mM MgCl2 and various concentrations of Gdn-HCl were placed in a Cary-Eclipse fluorimeter, and the fluorescence emission spectra were recorded at 20 °C by exciting the tryptophan residues in PA at 295 nm and monitoring the emitted light at 334 nm. The data were fit to a three-state transition in the absence of CMG2 as described previously.[15]

Pulse Proteolysis Assay

The method described by Young and co-workers was used to conduct the pulse proteolysis experiment.[18] PA (100 μg, 6 μM) or PA with 48 μg (12 μM) of CMG2 was incubated overnight at room temperature in 200 μL of 20 mM Tris buffer (pH 8.0) containing 150 mM NaCl, 10 mM CaCl2, and 1 mM MgCl2. The next day, 20 μL of 5 mg/mL thermolysin prepared in 2.5 M NaCl and 10 mM CaCl2 was added to the 200 μL of PA and PACMG2 complex samples and incubated at room temperature for various periods of up to 120 min. Aliquots (15 μL) were withdrawn at the different time points, to which 5 μL of 50 mM EDTA and 4 μL of 6× SDSPAGE sample buffer were added to stop the proteolysis. The solution was then boiled for 5 min, and 15 μL of the solution was run on a 15% SDSPAGE gel.

pH* Titration Studies

PA (0.5 nmol) and the PACMG2 complex (0.5 nmol of PA and 2.5 nmol of CMG2) were placed in 100 μL of buffer with different pH* values (4.5–9.0) that contains 20 mM CHES, 20 mM HEPES, 20 mM MES, 50 mM NaCl, and 1 mM MgCl2 and incubated for 50 h at 37 °C. The pH* of the buffer was adjusted with diluted DCl or NaOD. The reaction was stopped by adding 5 μL of formic acid, and the protein was freed from the buffer salts using an Ultra Micro Spin C4 column (Nest Group) according to the manufacturer’s instructions and dried in a Speed Vac. The protein was redissolved in 100 mM ammonium bicarbonate and digested with Lys-C alone, a combination of Lys-C and Glu-C, or a combination of Lys-C and chymotrypsin as described above. The resulting digests were dried in a Speed Vac, redissolved in 0.1% TFA, and then analyzed by LC–MS/MS using an LTQ-Orbitrap XL mass spectrometer as described previously.[17] The pseudo-first-order rate constant (k) of the HDX reaction was determined as described above, and the k values were plotted as a function of pH*, from which the pKa of each histidine residue and the half-life (t1/2) of the HDX reaction were determined.[17]

Structural Analysis

A comparison of protein structures was performed using PyMOL (Molecular Graphics System software, DeLano Scientific, Palo Alto, CA). The structural data of PA (PDB entry 3Q8B) and the PACMG2 complex (PDB entry 1T6B) deposited in the Protein Data Bank were used in the comparison. The same structural data were used to obtain the ASA (solvent accessible surface are) values for the C2 atoms of the histidine residues using GETAREA.[19]

Results and Discussion

Stability of PA and PA Bound to CMG2

To investigate how the stability of PA changes upon binding to CMG2, we conducted Gdn-HCl-induced equilibrium unfolding experiments on PA alone and PA complexed with CMG2, using His-HDX-MS. Histidine residues in a protein that are protected (to at least a certain extent) from the solvent become exposed to solvent upon unfolding of the protein caused by increasing concentrations of Gdn-HCl, which subsequently increases the magnitude of HDX rates for the histidine residues as the protein unfolds. The histidine residues we monitored were His211, His253 (domain 1′), His336 (domain 2), and His616 (domain 4). Four peptides containing these four histidine residues, each containing one histidine residue, were detected by LC–MS/MS (Table S1 of the Supporting Information), and their precursor ion spectra were used to calculate the pseudo-first-order rate constants (k) for their HDX reactions. During the study, it became apparent that the HDX rates obtained in the Gdn-HCl solution must be corrected upward. This is because the concentration of water in a highly concentrated Gdn-HCl solution (e.g., 5 M Gdn-HCl) is significantly lower than the concentration of water in a solution without Gdn-HCl. This means that the amount of a heavy water molecule (D2O) available in such a solution in a defined volume is significantly small, causing us to underestimate the HDX rates. We determined the relationship between the water and Gdn-HCl concentrations in various concentrations of Gdn-HCl solutions, from which an equation to correct upward the experimentally obtained HDX rates was obtained (see the Supporting Information). All the HDX rates measured in Gdn-HCl solutions were corrected using this equation. In Figure 2, Gdn-HCl-induced denaturation curves of PA alone (dashed line) and PA complexed with CMG2 (solid line) monitored at these four histidine residues are shown. PA denatured rapidly at very low Gdn-HCl concentrations, which prevented determination of the Cm value (midpoint of the Gdn-HCl-induced unfolding transition) for PA alone accurately. Nevertheless, we estimated the Cm values by visual inspection, which were ≈0.2, ≈0.2, and ≈0.5 M for His211, His253, and His616, respectively (Table 1). The Cm value at His336 could not be determined, because this histidine is already exposed well to solvent in the native structure as indicated by the high HDX rate for this residue at 0 M Gdn-HCl (Figure 2C, dashed line). The Cm values for PA complexed with CMG2 were ∼2–5-fold larger than those for PA alone (approximately 1 M at all four histidine residues) as shown in Table 1. The data in Figure 2 are representative of three separate experiments. The values of Cm (molar) for the PACMG2 complex were reproducible to ±12%. His211 is ∼70 Å from the binding interface. Thus, our data indicate that PA is stabilized throughout most of the protein by receptor binding, and the unfolding of these residues, despite being located in different domains, occurs at concomitant Gdn-HCl concentrations. In addition to the Cm values, we were able to estimate the standard state Gibbs free energy values from linear extrapolation of the His-HDX values as a function of denaturant, in the presence of CMG2. The calculated ΔG° values were approximately 4–5 kcal mol–1 at all four histidine residues (Table 1), suggesting that all are stabilized to a similar extent.
Figure 2

Gdn-HCl denaturation curves of PA alone (---) and PA complexed with CMG2 (—). PA and the PA–CMG2 complex were incubated in 100 mM HEPES (pH* 7.5) at 37 °C for 48 h in various concentrations of Gdn-HCl. After the incubation, the protein was digested and the resulting peptides were analyzed by LC–MS/MS. The HDX rates of four histidine residues, His211 (A), His253 (B), His336 (C), and His616 (D), were monitored to follow the Gdn-HCl-induced denaturation of PA.

Table 1

Transition Midpoints and Stabilities for the Gdn-HCl-Induced Unfolding of PA and PA Complexed with CMG2

  PA
PA–CMG2
residuedomainCm (M)ΔG (kcal mol–1)Cm (M)aΔG (kcal mol–1)
His2111≈0.21.00 ± 0.045.17
His2531≈0.21.03 ± 0.044.36
His33621.01 ± 0.084.37
His6164≈0.51.08 ± 0.065.11

The standard errors are associated with the sigmoidal curve fitting.

Gdn-HCl denaturation curves of PA alone (---) and PA complexed with CMG2 (—). PA and the PACMG2 complex were incubated in 100 mM HEPES (pH* 7.5) at 37 °C for 48 h in various concentrations of Gdn-HCl. After the incubation, the protein was digested and the resulting peptides were analyzed by LC–MS/MS. The HDX rates of four histidine residues, His211 (A), His253 (B), His336 (C), and His616 (D), were monitored to follow the Gdn-HCl-induced denaturation of PA. Previous fluorescence and 19F NMR unfolding experiments in urea have shown that PA unfolds in two transitions, the first transition being assigned to the unfolding of domains 1′–4 and the second transition being mainly due to the PA20 domain, which after cleavage with furin can freely dissociate and is stable on its own.[11,14,15] Here, we followed the Gdn-HCl-induced unfolding of PA by fluorescence in the presence of CMG2, where we have labeled CMG2 with 4-fluorotryptophan (4-FTrp). This effectively eliminates the fluorescence contribution from the sole tryptophan (Trp59) of CMG2, because 4-FTrp is a nonfluorescent analogue of tryptophan (see the inset of Figure 3).[20] The structure of CMG2 is largely unchanged upon labeling, as evidenced by the far-UV CD spectrum of wild-type (WT) CMG2 and 4-FTrpCMG2 (Figure S2 of the Supporting Information). Gdn-HCl-induced denaturation curves of PA alone and PA complexed with 4-FTrpCMG2 are shown in Figure 3. As we observed previously in urea, PA undergoes two transitions by fluorescence, which we again have assigned to the unfolding of domains 1′–4 constituting the PA63 region of PA at a low Gdn-HCl concentration (∼0.2 M) and to the PA20 domain at higher (∼1.3 M) Gdn-HCl concentrations.[11] In the presence of CMG2, we observed one single transition at a Cm of ∼1.3 M, suggesting that domains 1′–4 were significantly stabilized by receptor binding. We did not see a further increase in stability above that of the PA20 domain, suggesting that receptor binding largely stabilizes residues up to the PA20 region. In any case, these results agree well with the results obtained with the His-HDX-MS method.
Figure 3

Gdn-HCl denaturation curves of PA alone (○) and PA complexed with CMG2 (●). The fluorescence emission spectra of PA alone and PA complexed with 4-FTrpCMG2 in 100 mM HEPES (pH 7.5) containing 1 mM MgCl2 and various concentrations of Gdn-HCl were recorded by exciting the tryptophan residues in PA at 295 nm and monitoring the emitted light at 334 nm. The inset shows fluorescence emission spectra of PA and PA complexed with 4-FTrpCMG2.

The standard errors are associated with the sigmoidal curve fitting. Gdn-HCl denaturation curves of PA alone (○) and PA complexed with CMG2 (●). The fluorescence emission spectra of PA alone and PA complexed with 4-FTrpCMG2 in 100 mM HEPES (pH 7.5) containing 1 mM MgCl2 and various concentrations of Gdn-HCl were recorded by exciting the tryptophan residues in PA at 295 nm and monitoring the emitted light at 334 nm. The inset shows fluorescence emission spectra of PA and PA complexed with 4-FTrpCMG2.

Protease Susceptibility of PA and PA Bound to CMG2

Resistance to proteolysis is an effective way to probe accessibility to unfolded conformations in a protein, and we hypothesized that CMG2 binding would “tighten” the structure of the protein and decrease the rate of proteolytic degradation.[18] To test whether binding of CMG2 stabilizes PA against proteolysis, we incubated PA and the PACMG2 complex (1:2 ratio) at room temperature with thermolysin for different periods of time and analyzed the resulting reactions by SDSPAGE. In the case of PA alone, the undigested PA band disappeared within 30 s and appeared to be cleaved into two fragments (50 and 40 kDa) (Figure 4A). The two fragments, however, did not last long, fading away within 60 min. In the case of PA complexed with CMG2, the undigested band similarly disappeared within 30 s; however, the generated 50 kDa band was clearly seen even after incubation for 120 min (Figure 4B). The 40 kDa band faded away also within 60 min. To determine the thermolysin cleavage site, we analyzed the PACMG2 complex treated with thermolysin by LC–MS. We observed one major peak, in addition to the peaks that correspond to thermolysin and CMG2. The major peak gave a mass of 47007.4 Da and likely encompasses the 50 kDa band. The molecular weight matched well to the calculated molecular weight of the C-terminal portion of PA, Ile326Gly745 (47002.5 Da). Thus, the 50 kDa band is likely the C-terminal portion of PA produced by the hydrolysis between Asp315 and Ile316. The site has a preferred sequence recognized by this protease (X-Ile, X-Leu, X-Val, or X-Phe, where X is any amino acid)[21] and falls within the flexible region (His304Ser319) that cannot be observed in the crystal structures of PA or the PACMG2 complex.[4,8,22] The thermolysin resistance of the C-terminal fragment suggests that CMG2 remains bound to the C-terminal fragment after the proteolytic cleavage, thus providing continued resistance against thermolysin.
Figure 4

Proteolysis of PA alone (A) and PA complexed with CMG2 (B) by thermolysin. PA or PA complexed with CMG2 (100 μg) was incubated with 100 μg of thermolysin at room temperature for various periods of time (up to 120 min). Aliquots were withdrawn at the different time points and run on a 15% SDS–PAGE gel.

Proteolysis of PA alone (A) and PA complexed with CMG2 (B) by thermolysin. PA or PA complexed with CMG2 (100 μg) was incubated with 100 μg of thermolysin at room temperature for various periods of time (up to 120 min). Aliquots were withdrawn at the different time points and run on a 15% SDSPAGE gel.

pKa Values and His-HDX Rates

In previous studies, we compared, using His-HDX-MS, the effect of CMG2 binding on the rate of exchange at pH* 9.5;[14] however, we were unable to determine the pKa values of the histidines, which this technique also allows. Therefore, in a manner similar to our previous work, we conducted a pH* titration study on PA alone and the PACMG2 complex using His-HDX-MS. The protein was deuterated in different pH* buffers (4.5–9.0), digested, and then analyzed by LC–MS/MS. All 10 histidine residues were detected in different peptides (Table S2 of the Supporting Information). The rate constants (k) for HDX of those histidine residues were calculated directly from their precursor ion spectra. The obtained k values as a function of pH* for six histidine residues (His86, His263, His304, His310, His336, and His597) are shown in Figure 5. We could not obtain interpretable sigmoid curves for His211, His253, His299, and His616 because of their slow HDX rates. All the histidine residues in Figure 5 gave simple sigmoid curves corresponding to a single pKa except for His263 in PA, which showed a steep rise above pH* 7 without an explicit inflection point (Figure 5B, dashed line). We believe this curve reflects the increased local conformational fluctuation and reversible unfolding around this residue at alkaline pH*, causing the histidine residue to be exposed more to solvent, rather than reflecting the acid dissociation of this residue. The phenomenon was not observed for the same residue in the PACMG2 complex (Figure 5B, solid line), suggesting that binding to the receptor increases the stability of this region against alkaline pH*. The k value for His336 (Figure 5E, solid line) in the PACMG2 complex was too low to produce interpretable sigmoidal curves.
Figure 5

pH* dependence of the k for HDX at the imidazole group of six histidine residues in PA alone (---) and PA complexed with CMG2 (—). PA and the PA–CMG2 complex were incubated at different pH* values (4.5–9.0) at 37 °C for 50 h. After the incubation, the protein was digested and the resulting peptides were analyzed by LC–MS/MS. The pH* dependencies of the k values for HDX for (A) His86, (B) His263, (C) His304, (D) His310, (E) His336, and (F) His597 are shown.

Measured pKa values from the sigmoid curves for His86, His304, His310, His336, and His597 are shown in Table 2. Significant changes in pKa for His86 and His310 were observed, which was surprising given that His86 is >90 Å from the binding interface. In general, the pKa of histidines depends on several factors; however, the lower the pKa (<6), the stronger the tendency to be buried and uncharged at neutral pH, while a higher pKa (>7.5) generally reflects the greater potential for charge–charge interactions. The pKa of His86 decreased 0.61 pH unit upon binding to CMG2 (from ∼6.7 to 6.1), while the pKa of His310 increased 1.68 pH units. In previous work, we compared the distances of the histidine residues to potential hydrogen bond donors and/or acceptors and in general found that the distances became shorter in the presence of CMG2.[14] Indeed, for His86, the distance to the Gln121 backbone carbonyl decreases from 3.43 to3.07 Å, and this decreased distance is likely reflected in a slight lowering of the pKa. In contrast to that of His86, the pKa of His310 increased 1.68 pH units upon binding to CMG2, from 6.26 to 8.06. We are not able to offer an interpretation of the observed pKa change of this residue because His310 is not observed in the crystal structures of PA and the PACMG2 complex. However, the increased pKa suggests that one or more acidic side chains (e.g., Asp or Glu) may come close to His310 upon binding to CMG2. Indeed, Glu308, Glu302, and Asp315 are local candidates for interacting with His310.
Table 2

pKa and t1/2 Values of Histidine Residues in PA and the PA–CMG2 Complexa

  pKa
t1/2 (day)
residuedomainPAPA–CMG2PAPA–CMG2
His8616.71 ± 0.046.10 ± 0.120.57 ± 0.010.55 ± 0.03
His2111NDbNDb20.77c24.11c
His2531NDbNDb>50c>50c
His2632NDb6.77 ± 0.151.13c12.45 ± 0.85
His2992NDbNDb7.17c7.95c
His30426.26 ± 0.186.19 ± 0.062.26 ± 0.122.71 ± 0.07
His31026.38 ± 0.258.06 ± 0.292.14 ± 0.201.50 ± 0.02
His33627.25 ± 0.13NDb1.26 ± 0.0913.98c
His59748.28 ± 0.048.49 ± 0.040.55 ± 0.010.42 ± 0.01
His6164NDbNDb33.48c33.79c

The standard errors are associated with the sigmoidal curve fitting.

The pKa could not be determined mainly because of the slow HDX rate.

Calculated from k at pH 9.0 instead of using kmax, because kmax could not be obtained because of the lack of an interpretable sigmoidal curve.

pH* dependence of the k for HDX at the imidazole group of six histidine residues in PA alone (---) and PA complexed with CMG2 (—). PA and the PACMG2 complex were incubated at different pH* values (4.5–9.0) at 37 °C for 50 h. After the incubation, the protein was digested and the resulting peptides were analyzed by LC–MS/MS. The pH* dependencies of the k values for HDX for (A) His86, (B) His263, (C) His304, (D) His310, (E) His336, and (F) His597 are shown. The standard errors are associated with the sigmoidal curve fitting. The pKa could not be determined mainly because of the slow HDX rate. Calculated from k at pH 9.0 instead of using kmax, because kmax could not be obtained because of the lack of an interpretable sigmoidal curve. In addition to His86 and His310, we were able to determine the pKa values of His263 (for only the PACMG2 complex), His304, His336 (for only PA), and His597. The pKa of His263 in the PACMG2 complex was determined to be 6.77, which is close to the intrinsic pKa value of a histidine residue (pKa ≈ 6.5),[12] suggesting little electrostatic influence of the neighboring groups on this residue. The pKa of His336 in PA was slightly higher (7.25) than the intrinsic pKa value of the histidine residue, suggesting there is a moderate influence of the electron-donating group(s) around this residue. The pKa values of His597 in both PA and the PACMG2 complex were shifted almost 2 pH units toward alkaline values (≥8), indicating there is a negatively charged group(s) in the proximity of this histidine. As expected, the imidazole ring of His597 is in the proximity of the carboxyl group of Asp608 and likely forms a salt bridge to this residue, in agreement with the crystal structure.[14] We previously reported the half-lives [t1/2 (days)] of the HDX reactions of histidine residues in PA.[14] Those t1/2 values were calculated from the HDX rates obtained at a single pH* (9.5). In this study, we calculated the t1/2 values from the maximal rate constant (kmax) obtained from the plateau to the alkaline side of the sigmoid titration curve as described previously.[17] The t1/2 values calculated in this way are considered to be more accurate, because they are calculated from the kmax values obtained from the pH* titration curves fit to multiple data points. The t1/2 values for His86, His263 (for only the PACMG2 complex), His304, His310, His336 (for only PA), and His597 were successfully determined from their kmax values and are listed in Table 2. We could not obtain interpretable sigmoidal curves for the remaining histidine residues mainly because of their slow HDX rates; therefore, the t1/2 values for those histidine residues were calculated from the k obtained at pH* 9.0. The significant increases in t1/2 values due to receptor binding were observed for three histidine residues, His263, His304, and His336, suggesting that their solvent accessibilities decreased upon receptor binding. The increased t1/2 value for His263 is probably due to the increased level of stabilization of the local structure against alkaline pH* that occurs upon receptor binding as discussed above. Because His263 and His336 are observed in structures of PA and the PACMG2 complex, we compared the solvent accessible surface area (ASA) values for the C2 atoms of the histidine residues. The ASA values for His263 and His336 in both structures were comparable (His263, 15.5 Å2 for PA and 11.1 Å2 for the PACMG2 complex; His336, 20.3 Å2 for PA and 18.1 Å2 for the PACMG2 complex). Therefore, we cannot explain the results based on the ASA values. This discrepancy may reflect the difference in protein structures in the solution and crystals. The HDX reaction of the C2 hydrogen of the imidazole group occurs only when the neutral and protonated forms of the imidazole group are in equilibrium and the C2 atom is in direct contact with water.[23,24] Therefore, the HDX reaction can be diminished when the number of water molecules assisting the acid–base equilibrium of the imidazole group or having contact with the C2 atom is reduced. Thus, our results indicate that receptor binding tightens the structure of PA, which leads to expelling water molecules around these histidine residues.

Long-Range Stabilization of PA upon CMG2 Binding

Our Gdn-HCl-induced unfolding experiments clearly show that PA is stabilized by CMG2, and the stabilization occurs not only in the domain that directly interacts with CMG2 (His616 located in domain 4) but also in domains that do not have direct contact with CMG2 (His211 and His253 located in domain 1′). Thus, we can safely say that both our combined His-HDX, fluorescence, and protease sensitivity assays indicate that the stabilization afforded by binding of CMG2 occurs up to His211 (which is ∼70 Å from the binding interface) does not seemingly further influence the stability of the PA20 domain. Nonetheless, our pH titration study using His-HDX-MS revealed that the microenvironment around histidine residues in PA20, domain 2, and domain 4 changes upon receptor binding. The altered pKa of His86 in the PA20 domain indicates that the binding to CMG2 influences the microenvironment of His86 even though the residue is far from the CMG2 binding interface (>90 Å).

Influence of Receptor Binding on Domain 2 and Domain 4 Dynamics

How does receptor binding influence residues that are far from the binding interface? Previous experiments by Feld and co-workers have indicated that domain 2 and domain 4 are part of a hinge that dictates the oligomeric assembly of PA63,[25] such that a tighter interaction favors the formation of heptamers, whereas a weaker interaction may favor the formation of octamers. This implies that domain 2 and domain 4 are capable of hingelike dynamic motions that likely give rise to an overall plasticity in the protein. By anchoring the domain 2–domain 4 interface, hingelike motions are prevented, which in turn would effectively stabilize domain–domain interactions and other noncovalent interactions within the protein.

The PA–CMG2 Complex as a Potential Immunogen in a Future Anthrax Vaccine

PA is the key component of anthrax vaccines currently licensed as well as vaccines under development.[26] Efforts to develop protective adjuvants that do not require the use of a cold chain for storage in areas where a cold chain is not accessible or feasible are ongoing. Our study finds that CMG2 thermodynamically stabilizes PA, and thus, CMG2 may prevent structural perturbations to the protein under long-term storage conditions. Further, the addition of CMG2 slowed the rate of proteolysis by thermolysin. Addition of CMG2 to the vaccine formulation may prevent premature degradation of the protein postinjection, possibly allowing for a greater proportion of PA to ultimately be presented on antigen-presenting cells. Finally, depletion of the actual PA concentration amenable for interacting with the host immune system likely occurs because of the interaction of PA with receptors present on the surface of host cells, and the inclusion of CMG2 in a vaccine formulation should prevent such a depletion of PA.

His-HDX-MS as a Tool To Investigate Protein Stability

Studies have shown that amide HDX in combination with mass spectrometry can be used to provide information about the stability of specific regions within a protein.[27−29] This work demonstrates that His-HDX-MS is complementary to amide HDX, and to other conventional methods such as fluorescence spectroscopy and CD spectroscopy for monitoring protein stability. The advantages of this method over other methods include (1) the ability to follow the side chain stability at a single histidine, which may be more sensitive to the folded state of a protein (because it may be the last part to be stabilized),[30] and to monitor the stabilities of different sites within a protein simultaneously, (2) compared to NMR or CD, the absence of a requirement for large amounts of protein, (3) the fact that proteins do not have to be pure, because mass spectrometry can detect peptide masses even in complex mixtures, and (4) the fact that proteins can be in seemingly any environment, such as a soluble monomer or part of a large oligomeric multiprotein complex within the membrane. These advantages will allow us to study the stabilities of proteins in more complex structures and cellular milieu.
  28 in total

1.  Atomic mutations at the single tryptophan residue of human recombinant annexin V: effects on structure, stability, and activity.

Authors:  C Minks; R Huber; L Moroder; N Budisa
Journal:  Biochemistry       Date:  1999-08-17       Impact factor: 3.162

2.  Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation.

Authors:  D Borden Lacy; Darran J Wigelsworth; Roman A Melnyk; Stephen C Harrison; R John Collier
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

3.  Receptor-specific requirements for anthrax toxin delivery into cells.

Authors:  G Jonah A Rainey; Darran J Wigelsworth; Patricia L Ryan; Heather M Scobie; R John Collier; John A T Young
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-01       Impact factor: 11.205

4.  Crystal structure of the anthrax toxin protective antigen.

Authors:  C Petosa; R J Collier; K R Klimpel; S H Leppla; R C Liddington
Journal:  Nature       Date:  1997-02-27       Impact factor: 49.962

5.  Hydrogen-deuterium exchange kinetics of the C-2 protons of imidazole and histidine compounds.

Authors:  J H Bradbury; B E Chapman; F A Pellegrino
Journal:  J Am Chem Soc       Date:  1973-09-05       Impact factor: 15.419

6.  Comparison of the specificities of various neutral proteinases from microorganisms.

Authors:  K Morihara; H Tsuzuki; T Oka
Journal:  Arch Biochem Biophys       Date:  1968-03-11       Impact factor: 4.013

7.  Denaturant sensitive regions in creatine kinase identified by hydrogen/deuterium exchange.

Authors:  Hortense Mazon; Olivier Marcillat; Eric Forest; Christian Vial
Journal:  Rapid Commun Mass Spectrom       Date:  2005       Impact factor: 2.419

8.  Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin.

Authors:  M Varughese; A V Teixeira; S Liu; S H Leppla
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

9.  Crystal structure of a complex between anthrax toxin and its host cell receptor.

Authors:  Eugenio Santelli; Laurie A Bankston; Stephen H Leppla; Robert C Liddington
Journal:  Nature       Date:  2004-07-04       Impact factor: 49.962

10.  Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin.

Authors:  K R Klimpel; S S Molloy; G Thomas; S H Leppla
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

View more
  6 in total

1.  Stability of domain 4 of the anthrax toxin protective antigen and the effect of the VWA domain of CMG2 on stability.

Authors:  Sireesha Mamillapalli; Masaru Miyagi; James G Bann
Journal:  Protein Sci       Date:  2017-02       Impact factor: 6.725

2.  Determination of Histidine pKa Values in the Propeptides of Furin and Proprotein Convertase 1/3 Using Histidine Hydrogen-Deuterium Exchange Mass Spectrometry.

Authors:  Johannes Elferich; Danielle M Williamson; Larry L David; Ujwal Shinde
Journal:  Anal Chem       Date:  2015-07-15       Impact factor: 6.986

3.  The Disulfide Bond Cys255-Cys279 in the Immunoglobulin-Like Domain of Anthrax Toxin Receptor 2 Is Required for Membrane Insertion of Anthrax Protective Antigen Pore.

Authors:  Pedro Jacquez; Gustavo Avila; Kyle Boone; Agamyrat Altiyev; Jens Puschhof; Roland Sauter; Emma Arigi; Blanca Ruiz; Xiuli Peng; Igor Almeida; Michael Sherman; Chuan Xiao; Jianjun Sun
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

Review 4.  Roles of Anthrax Toxin Receptor 2 in Anthrax Toxin Membrane Insertion and Pore Formation.

Authors:  Jianjun Sun; Pedro Jacquez
Journal:  Toxins (Basel)       Date:  2016-01-22       Impact factor: 4.546

5.  Role of the Antigen Capture Pathway in the Induction of a Neutralizing Antibody Response to Anthrax Protective Antigen.

Authors:  Anita Verma; Miriam M Ngundi; Gregory A Price; Kazuyo Takeda; James Yu; Drusilla L Burns
Journal:  mBio       Date:  2018-02-27       Impact factor: 7.867

6.  Binding of the von Willebrand Factor A Domain of Capillary Morphogenesis Protein 2 to Anthrax Protective Antigen Vaccine Reduces Immunogenicity in Mice.

Authors:  Fabiana Freire Mendes de Oliveira; Sireesha Mamillapalli; Srinivas Gonti; Robert N Brey; Han Li; Jarad Schiffer; Arturo Casadevall; James G Bann
Journal:  mSphere       Date:  2020-01-15       Impact factor: 4.389

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.